D. E. Shaw & Co., Inc. Incyte Corp Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Incyte Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 407,345 shares of INCY stock, worth $33.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
407,345
Previous 862,595
52.78%
Holding current value
$33.2 Million
Previous $52.2 Million
46.89%
% of portfolio
0.02%
Previous 0.05%
Shares
30 transactions
Others Institutions Holding INCY
# of Institutions
726Shares Held
202MCall Options Held
500KPut Options Held
258K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.51 Billion21.22% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.74 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.1MShares$1.64 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.6MShares$1.19 Billion0.6% of portfolio
-
State Street Corp Boston, MA9.88MShares$806 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $18.2B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...